GE HealthCare Hired New Chief AI Officer
The company appointed former Medtronic leader Rodolphe Katra to oversee its portfolio of 134 FDA-authorized AI tools.
Updated on Sept. 29, 2026 in Artificial Intelligence
Live Poll
Do you trust artificial intelligence to improve the speed and accuracy of your medical care?
GE HealthCare has appointed Rodolphe Katra as its new chief AI officer, succeeding Parminder Bhatia. Katra, who previously served in an identical role at Medtronic, arrives as the company expands its generative AI clinical research.
Why it matters
The appointment signals a strategic shift toward integrating generative AI into medical device workflows to accelerate care. By connecting imaging, notes, and patient data, the company aims to move from individual device sales to broader automated precision health ecosystems.
GE HealthCare has secured FDA authorization for 134 AI-powered devices to date. In research settings, the company's Intelligent Radiation Therapy workflow, developed with Mass General Brigham, reduced intake-to-treatment time from 30 days to 8 days across a cohort of 11,000 plans.
The players
GE HealthCare
A global medical technology company focused on imaging, ultrasound, and patient care solutions with a portfolio of over 130 AI-enabled devices.
Rodolphe Katra
The incoming chief AI officer at GE HealthCare who previously led AI strategy at Medtronic and holds over 150 patents.
Mass General Brigham
An integrated academic healthcare system that partners with GE HealthCare to research generative AI applications in radiation oncology.
Taha Kass-Hout
The Global Chief Science and Technology Officer at GE HealthCare who oversees the company's research and AI development roadmap.
Parminder Bhatia
The former GE HealthCare chief AI officer who transitioned to a senior AI leadership role at Edwards Lifesciences.
The details
The radiation therapy initiative uses generative AI to automate the collation of patient data, including imaging scans, physician notes, and medical reports. By aggregating these disparate data streams, the system accelerates the generation of treatment plans. Rodolphe Katra, who holds over 150 patents, will report to Global Chief Science and Technology Officer Taha Kass-Hout to oversee these clinical workflows.
Timeline
2023: Rodolphe Katra began his tenure as chief AI officer at Medtronic.
Summer 2026: Former GE HealthCare AI head Parminder Bhatia joined Edwards Lifesciences.
September 29, 2026: GE HealthCare announced the appointment of Rodolphe Katra.
The Tech Race
This leadership transition follows the technical roadmap established by the GE HealthCare and Mass General Brigham Intelligent Radiation Therapy collaboration. The company is now pivoting to scale this research-proven efficiency across its broader clinical device ecosystem.
The transition indicates a shift toward shorter waiting times for complex radiation treatment as clinical tools move from research into standard practice. Clinicians can expect increased integration of automated data-collation features in upcoming device software updates.
The takeaway
The move underscores the industry's focus on translating clinical AI research into administrative and treatment efficiency. Stakeholders should monitor the company's Q4 2026 earnings report for updates on the integration of these AI tools into its commercial product stack.
Further reading
For more on the industry shift toward generative diagnostic tools, explore our full Artificial Intelligence coverage.
Live Poll
Do you trust artificial intelligence to improve the speed and accuracy of your medical care?
